Micro Therapeutics, Inc. recalls
Micro Therapeutics, Inc. is named on 4 recalls in Recall Relay's records since November 2023, from FDA (7 recalled products: FDA lists each product as its own recall); the most recent was June 25, 2026.
All 7 recalled products, newest first.
-
Class IIofficial
Micro Therapeutics, Inc. recalls Pipeline Flex Embolization Device with Shield Technology REF PED2-300-12 UDI-DI code: 00763000448806 he PipeliDue to incorrect label/product dimensions. Product is supposed to be 3.00 mm in diameter, but unit is packaging was a 2.50 mm in diameter.
-
Class IIofficial
Micro Therapeutics, Inc. recalls Pipeline Flex Embolization Device with Shield TechnologyIncorrect labeling - embolization devices labeled as 3.0 mm x 20 mm implants contain 12 mm implants, and devices labeled as 3.0 mm x 12 mm implants contain 20 mm implants.
-
Class IIofficial
Micro Therapeutics, Inc. recalls Pipeline Flex Embolization Device with Shield TechnologyIncorrect labeling - embolization devices labeled as 3.0 mm x 20 mm implants contain 12 mm implants, and devices labeled as 3.0 mm x 12 mm implants contain 20 mm implants.
-
Class Iofficial
Micro Therapeutics, Inc. recalls Medtronic Pipeline Vantage Embolization Device with Shield TechnologyUse of embolization device with diameters greater-than-or-equal-to 4mm may lead to incomplete wall apposition and/or braid deformation (fish-mouthing/braid narrowing/braid collapse) noted during procedure and post-procedure, typically noted at 6-12 month imaging follow-up, potentially can lead to thrombosis and/or serious adverse events. Higher risk in females less-than-or-equal-to 45 years of age
-
Class Iofficial
Micro Therapeutics, Inc. recalls Medtronic Pipeline Vantage Embolization Device with Shield TechnologyUse of embolization device with diameters greater-than-or-equal-to 4mm may lead to incomplete wall apposition and/or braid deformation (fish-mouthing/braid narrowing/braid collapse) noted during procedure and post-procedure, typically noted at 6-12 month imaging follow-up, potentially can lead to thrombosis and/or serious adverse events. Higher risk in females less-than-or-equal-to 45 years of age
-
Class IIofficial
Micro Therapeutics, Inc. recalls The Apollo Onyx Delivery Microcatheter (AOMC) is a DMSO-compatibleEuropean version of microcatheter were distributed within US which contain a different "Indications for Use".
-
Class IIofficial
Micro Therapeutics, Inc. recalls The Apollo Onyx Delivery Microcatheter (AOMC) is a DMSO-compatibleEuropean version of microcatheter were distributed within US which contain a different "Indications for Use".
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Micro Therapeutics, Inc. or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts